by Michael Nevradakis, Ph.D. Pfizer said its mRNA flu vaccine outperformed conventional flu vaccines in a Phase 3 clinical trial. The New England Journal of Medicine (NEJM) last…
by Michael Nevradakis, Ph.D. Pfizer said its mRNA flu vaccine outperformed conventional flu vaccines in a Phase 3 clinical trial. The New England Journal of Medicine (NEJM) last…